Cargando…
Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer
Despite the promising outcomes of immune checkpoint blockade (ICB), resistance to ICB presents a new challenge. Therefore, selecting patients for specific ICB applications is crucial for maximizing therapeutic efficacy. Herein we curated 69 human esophageal squamous cell cancer (ESCC) patients’ tumo...
Autores principales: | Ko, Kyung-Pil, Zhang, Shengzhe, Huang, Yuanjian, Kim, Bongjun, Zou, Gengyi, Jun, Sohee, Zhang, Jie, Martin, Cecilia, Dunbar, Karen J., Efe, Gizem, Rustgi, Anil K., Zhang, Haiyang, Nakagawa, Hiroshi, Park, Jae-Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949073/ https://www.ncbi.nlm.nih.gov/pubmed/36824935 http://dx.doi.org/10.1101/2023.02.15.528539 |
Ejemplares similares
-
CRACD suppresses neuroendocrinal plasticity of lung adenocarcinoma
por: Kim, Bongjun, et al.
Publicado: (2023) -
CDH1 loss promotes diffuse-type gastric cancer tumorigenesis via epigenetic reprogramming and immune evasion
por: Zou, Gengyi, et al.
Publicado: (2023) -
CRACD loss promotes small cell lung cancer tumorigenesis via EZH2-mediated immune evasion
por: Zhang, Shengzhe, et al.
Publicado: (2023) -
Lysosomal TMEM9‐LAMTOR4‐controlled mTOR signaling integrity is required for mammary tumorigenesis
por: Zhang, Shengzhe, et al.
Publicado: (2022) -
Engineered hydrogel reveals contribution of matrix mechanics to esophageal adenocarcinoma and identifies matrix-activated therapeutic targets
por: Cruz-Acuña, Ricardo, et al.
Publicado: (2023)